Ascend Wellness (OTCMKTS:AAWH) reported first-quarter 2026 results that management said came in ahead of its guidance, as the cannabis operator pointed to improving retail mix, higher vertical sales ...

Samuel Brill (CEO & Director) highlighted federal reform momentum: "On April 23, the U.S. Department of Justice issued an order rescheduling medical cannabis from Schedule I to Schedule III." He added ...

Nemchenko provided Q2 expectations: "Looking ahead to Q2, we're expecting 2% to 3% top line growth, driven by the ramp-up of new store openings and more favorable seasonality across the comparable ...